Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system for the management of acute post-operative pain in a hospital setting, will become available in Germany, the U.K. and Ireland this week.

These countries represent the first markets to launch this product, and additional launches in other European countries are planned for the coming months.

NEC Electronics America Inc. introduced two new color, 21.3-inch diagonal amorphous-silicon thin-film transistor (TFT) liquid-crystal display (LCD) modules for medical imaging applications.

January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.

January 28, 2008 - Terumo Interventional Systems launches the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.

January 28, 2008 – Medtronic Inc. has launched a clinical trial to confirm the safety and efficacy of the Medtronic EnRhythm MRI SureScan pacing system, a pacemaker system to be developed and tested specifically for safe use in Magnetic Resonance Imaging (MRI) machines under specified scanning conditions.

January 28, 2008 - Arbor Surgical Technologies Inc. closed a $20 million dollar Series C financing round led by Medtronic Inc. as part of a licensing agreement, providing Medtronic with manufacturing, marketing and distribution rights to Arbor’s advanced trilobal pericardial valve technologies.

January 28, 2008 - MediGuide signed an agreement with Medtronic for co-development of medical positioning system-enabled products, providing Medtronic products with GPS-like navigation capabilities to enhance various procedures.

January 28, 2008 - Toshiba America Medical Systems Inc. said today the FDA cleared the new open-bore 1.5T Vantage Titan MR system, which will be commercially available in the first quarter of 2008.

The open-bore of the Vantage Titan is 18 percent larger than other 1.5T systems on the market, featuring a large 71-centimeter patient aperture.

Monitoring system maker Mennen Medical said an additional monitor, the VitaLogik 4000 Series, will soon be available for monitoring requirements in neonatology, pediatrics, cardiology, ICU, OR, and ER.

The product is available in two versions. The noninvasive VitaLogik 4000 and the invasive VitaLogik 4500 and has FDA clearance and CE mark.

MEDecision Inc. introduced Alineo, a collaborative healthcare management platform for addressing case management, disease management and utilization management.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now